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Volume 57, Number 5S Abstracts 33SA than group B (thrombotic, 3.6% vs 1.5%; P ¼ .02; device
related, 5% vs 0.5%; P < .0001).
Conclusions: Indwelling retrievable IVC ﬁlters were
associated with signiﬁcantly higher complication rates
than permanent ﬁlters. Both thrombotic and device related
complications were more common with retrievable ﬁlters.
Long term use of retrievable ﬁlters should be avoided,
especially considering the younger population in whom
they are placed.
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Objectives: Describe and quantify the effects of perfo-
rator sclerotherapy on venous ulcers (CEAP 6) without
axial reﬂux
Methods: Retrospective analysis of ultrasound (US)-
guided perforator injections from 1/2010-11/2012 iden-
tiﬁed 73 venous ulcers in 62 patients. Patients had no axial
reﬂux. Perforating vein identiﬁcation and closure were
assessed with US. Reﬂuxing perforators near the ulcer
were injected with polidocanol foam created in a 4:1
mixture with air. 98.4% of patients had US follow-up per-
formed 2-6 weeks after injection. Ulcers were divided into
two groups: group 1 healed ulcer(s); group 2 either healed
and recurred/never healed. All patients were treated with
compression therapy. Demographics, comorbidities, treat-
ment details and outcomes were analyzed. P # .05 was
signiﬁcant.
Results: 32 patients had healed ulcers; 30 had at least 1
non-healed ulcer. Comparisons of patients with healed vs
non-healed ulcers were: age 60.2 vs 61.3 years; male gender
50% vs 60%; history of deep vein thrombosis (DVT) 31.3%
vs 33.3% (P ¼ NS for all). Of the 73 total ulcers, 43 ulcers
were healed (group 1); 30 ulcers recurred/never healed
(group 2) for a healing rate of 59.9%. Initial ulcer size was
3.44 cm2 vs 15.1 cm2 (P ¼ NS).
189 injections were performed with a 53.8% success-
ful closure rate per injection. Successful thrombosis
occurred in 68.8% of group 1 vs 37.8% of group 2 (P
< .001). Group 1 ulcers averaged 2.2 injections per ulcer
vs 2.9 in group 2 (P ¼ .16). 24.7% of ulcers healed with
a single perforator injection. Post procedure DVTs were
seen: 5.8% of injections (11/189); four in group 1; seven
in group 2 (P ¼ NS). No other injection complications
were seen. 88.1% of group 1 ulcers had perforator
closure at the end of follow-up vs 67.8% of group 2
ulcers (P ¼ .038).
Conclusions: Successful thrombosis of pathologic
perforators with compression therapy increases ulcer heal-
ing and was found to be the only predictor of ulcer closure.Perforator closure may require multiple injections and is
associated with low DVT rates.
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Objectives: Previous studies have combined anasto-
motic, catheter-induced, and IFAA to achieve adequate
numbers for analysis, and have recommended repair of
asymptomatic IFAA with diameters $2.5 cm and all symp-
tomatic IFAA. This study evaluates the contemporary
management of IFAA, using these criteria.
Methods: Patients with IFAA were evaluated using
a standardized, prospectively maintained database by
a research consortium.
Results: From 2002-2012 236 IFAA were identiﬁed in
182 patients (mean age, 72; M:F, 16:1) at eight institutions.
Nonoperative mean diameter was 2.8 6 .7 cm; operative
diameter was 3.3 6 1.5 cm. IFAA location was: CFA
(191), SFA (34), and PFA (11). Synchronous aneurysms
(mean ¼ 1.7/patient) occurred in the aorta (181), iliac
(126), popliteal (96), hypogastric (63), mesenteric (17)
arteries, and contralateral SFA (7) and PFA (2). 66% of
repaired aneurysms were asymptomatic; other indications
included: claudication (18%), local pain (8%), nerve
compression (3%), rupture (3%), acute thrombosis (1%),
embolus (1%), and rest pain (.5%). Acute complications
(rupture, thrombosis, embolus) were associated (P < .05)
with FAA diameter >4 cm and intraluminal thrombus, but
not location. Mean diameter of symptomatic aneurysms
was: rupture, 5.7 6 1.3 cm; thrombosis, 4 6 1.1 cm; and
embolus, 3.66 .1 cm. 174 IFAAwere repairedwith interpo-
sition or bypass graft; three underwent endovascular repair.
There were two perioperative deaths at 30 days (MI,
MSOF); operative complications included wound infection
(6%), seroma (3%), and bleeding (2%). No amputations
occurred up to 5 years in either the nonoperative or operative
groups. Survivalwas: 3months¼99% (138), 1 year¼92% (n
¼ 104), and 5 years ¼ 81% (20) in operated patients.
